CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathwa
| Image |  |
|---|---|
| Description | scientific article published on 31 July 2013 |
| Author/s |
author: Jeffrey W. Tyner Brian Druker |
| Publication date | July 31, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |